AG
GENE

Aperio Group’s Genetic Technologies Ltd. GENE Stock Holding History

Aperio Group’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-238
Closed -$55K – 1992
2013
Q3 		$55K Sell
238
-125
-34% -$29.8K ﹤0.01% 1772
2013
Q2 		$84K Buy
+363
New +$94.2K ﹤0.01% 1603

Other funds holding GENE

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
APU
Alpine Partners USVI St. Thomas, U.S. Virgin Islands $30.1M AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Aperio Group's GENE Position: Q4 2013 in Review

Aperio Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2013, closing a stake of 238 shares — an estimated $55K sold.

Aperio Group first reported a position in GENE in Q2 2013 and held it in 2 quarters. The position peaked at $84K in Q2 2013. 5 funds tracked by Wall St. Rank hold GENE as of Q4 2013.

  • Aperio Group reported no remaining Genetic Technologies Ltd. position as of Q4 2013 after selling out during the quarter.
  • Aperio Group sold 238 Genetic Technologies Ltd. shares in Q4 2013, an estimated $55K.
  • Aperio Group first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 2 quarters.
  • Aperio Group's Genetic Technologies Ltd. position peaked at $84K in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2013.

Based on Aperio Group's 13F filing for Q4 2013, filed 30 Jan 2014.